Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-07-22

Clinical Trial Update: Reducing Diagnostic Error to Improve Patient Safety in COPD and Asthma (REDEFINE Study) [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update aimed at reducing diagnostic error to improve patient safety in COPD and asthma has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Illinois at Chicago | Conditions: COPD Asthma | Phase 3 | Status: COMPLETED | Results posted: 2021-07-22